For example, by binding to the 3′-UTR of FOS-like 2 (FOSL2), miR-143 can negatively regulate FOSL2 expression, suggesting that the UCA1/miR-143 axis may have potential therapeutic value for the treatment of cisplatin resistance in ovarian cancer patients. This evidence concerns the gene FOSL2 and ovarian carcinoma.